Phil Grayeski

KdT Ventures is an early-stage venture capital firm that invests in startups in the data, engineering, and biology sector.

Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials.

Raised $31,145,000.00 from U.S. Department of Defense.

Cirsium is a cutting-edge production technology utilize transient gene delivery in plants to manufacture high-quality genetic medicine.

Perceptive specializes in the design, development, and manufacturing of medical devices for the dentistry industry.

Raised $20,298,916.00 from Modi Ventures, Taihill Venture and Pacific Dental Services.

Andes develops an integrated microbial technology to help accelerate crop growth.

Raised $56,050,000.00 from Accelr8, Voyager Ventures, Germin8 Ventures, KdT Ventures, Cavallo Ventures, Yamaha Motor Ventures, Venturance, Leaps by Bayer, Builders VC and Accelr8.

Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.

Raised $1,000,004.00 from PROTOCOL — by GETTYLAB.

Dimension Inx specializes in developing regenerative microenvironments that give the body a blueprint to heal itself.

Raised $17,701,341.00 from Revolution’s Rise of the Rest Seed Fund, Portal Innovations, Alumni Ventures, Prime Movers Lab, Solas BioVentures and KdT Ventures.

StrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.

Raised $97,200,000.00 from Northpond Ventures, CaaS Capital Management, Takeda Ventures, Sarepta Therapeutics, Alexandria Venture Investments, Novo Holdings, UCB Ventures, UF Innovate Ventures, Pontifax and Octagon Capital Advisors.